MS
Morgan Stanley
MS has the edge over TRMK overall, supported by stronger fundamentals and stronger modeled upside.
TRMK
Trustmark Corporation
TRMK offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
TRMK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
TRMK's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like TRMK.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
TRMK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $42.45 | -11% |
| Forward | 11x | $47.84 | — |
| Fair | 12x | $48.11 | +0.6% |
| Current | 12x | $47.84 | — |
| Expensive | 15x | $60.55 | +27% |
Historical ranges are pointers, not guarantees.
TRMK has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
TRMK Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for TRMK, with profitability improving.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over TRMK on earnings, with more consistent year-over-year improvement.
TRMK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.21 | +5.6% |
| Q3 2026 | $3.99 | +9.3% |
| Q2 2026 | $3.93 | +11% |
| Q1 2024 | $2.56 | +68% |
| Q4 2023 | $2.70 | +131% |
| Q3 2023 | $1.57 | -27% |
| Q2 2023 | $1.70 | -5% |
| Q1 2023 | $1.52 | -24% |
| Q4 2022 | $1.17 | -50% |
TRMK's earnings per share have climbed steadily: $3.99 over the past year, up 9.3% from the year before, and higher year over year for eight quarters in a row.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over TRMK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
TRMK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $207.1M | +2.4% |
| Q2 2026 | $208.2M | +4.8% |
| Q1 2026 | $202.9M | +4.2% |
| Q4 2025 | $204.1M | +3.7% |
| Q3 2025 | $202.4M | +5.3% |
| Q1 2025 | $194.6M | +3.4% |
| Q4 2024 | $196.8M | +5.5% |
| Q3 2024 | $192.3M | +0.7% |
TRMK's revenue has grown year over year for eight quarters in a row: $207M last quarter, up 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -0.5 points |
| Q2 2026 | 37% | +2.7 points |
| Q1 2026 | 34% | 0 points |
| Q4 2025 | 35% | +1.7 points |
| Q3 2025 | 34% | +2 points |
| Q2 2025 | 35% | N/A |
| Q1 2025 | 34% | +7.3 points |
| Q4 2024 | 33% | +9.7 points |
TRMK has the edge over MS on profitability, with a higher operating margin.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
TRMK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $135.1M | +115% |
| Q2 2026 | $49.5M | +43% |
| Q1 2026 | $20.6M | -74% |
| Q4 2025 | $54.1M | -43% |
| Q3 2025 | $62.7M | +22% |
| Q1 2025 | $80.6M | +$144.2M |
| Q4 2024 | $95.3M | +67% |
| Q3 2024 | $51.2M | -48% |
TRMK has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
TRMK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -474K shares |
| 1 year | -3.8% | -2.3M shares |
| 3 years | -4.9% | -3M shares |
| 5 years | -8.2% | -5.2M shares |
| Available history | -10% | -6.5M shares |
TRMK has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $20.1M |
| Q2 2026 | $21.1M |
| Q1 2026 | $19.8M |
| Q4 2025 | $43M |
| Q3 2025 | $11M |
| Q2 2025 | $11M |
| Q1 2025 | $15M |
| Q4 2023 | — |
TRMK spent $104M buying back its own shares over the past year.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
TRMK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.2x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | 0.2x | Very low |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | -1.6x | Net Cash |
TRMK has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
TRMK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.1 | Neutral |
| Stochastic | 32.7 | Neutral |
TRMK's weekly RSI is 59 (neutral) and its Stochastic is 33 (neutral).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
TRMK PE vs Financial Services Sector
| Metric | TRMK | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.9% below |
| PE % | 47 | 63 | 16 pts below |
TRMK has the edge over MS on valuation relative to its sector.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
TRMK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $45.5 | 5.1% above |
| 20 week MA | $46.3 | 3.3% above |
| 50 week MA | $44.3 | 8.1% above |
| 100 week MA | $40.4 | 18% above |
| 200 week MA | $34.0 | 41% above |
TRMK has the edge over MS on trend strength, trading above more of its moving averages.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.
TRMK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $34.5 | $27.3 | -21% |
| 2021 | $27.3 | $32.1 | +17% |
| 2022 | $32.1 | $34.7 | +8.4% |
| 2023 | $34.7 | $27.9 | -20% |
| 2024 | $27.9 | $35.9 | +29% |
| 2025 | $35.9 | $40.1 | +12% |
| 2026 YTD | $40.1 | $47.8 | +19% |
TRMK has the edge over MS on returns for 2026, with the stronger performance.